BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alenezi WM, Fierheller CT, Recio N, Tonin PN. Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers. Genes (Basel) 2020;11:E856. [PMID: 32726901 DOI: 10.3390/genes11080856] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Rossi C, Cicalini I, Cufaro MC, Consalvo A, Upadhyaya P, Sala G, Antonucci I, Del Boccio P, Stuppia L, De Laurenzi V. Breast cancer in the era of integrating “Omics” approaches. Oncogenesis 2022;11. [DOI: 10.1038/s41389-022-00393-8] [Reference Citation Analysis]
2 Rofes P, Del Valle J, Torres-Esquius S, Feliubadaló L, Stradella A, Moreno-Cabrera JM, López-Doriga A, Munté E, De Cid R, Campos O, Cuesta R, Teulé Á, Grau È, Sanz J, Capellá G, Díez O, Brunet J, Balmaña J, Lázaro C. BARD1 Pathogenic Variants are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort. Genes (Basel) 2021;12:150. [PMID: 33498765 DOI: 10.3390/genes12020150] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Alenezi WM, Fierheller CT, Revil T, Serruya C, Mes-masson A, Foulkes WD, Provencher D, El Haffaf Z, Ragoussis J, Tonin PN. Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic BRCA1 and BRCA2 Variants. Genes 2022;13:697. [DOI: 10.3390/genes13040697] [Reference Citation Analysis]
4 Luo Y, Wu H, Huang Q, Rao H, Yu Z, Zhong Z. The Features of BRCA1 and BRCA2 Germline Mutations in Hakka Ovarian Cancer Patients: BRCA1 C.536 A>T Maybe a Founder Mutation in This Population. IJGM 2022;Volume 15:2773-86. [DOI: 10.2147/ijgm.s355755] [Reference Citation Analysis]
5 Dai L, Dai Y, Han J, Huang Y, Wang L, Huang J, Zhou Z. Structural insight into BRCA1-BARD1 complex recruitment to damaged chromatin. Mol Cell 2021;81:2765-2777.e6. [PMID: 34102105 DOI: 10.1016/j.molcel.2021.05.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Marsh DJ, Ma Y, Dickson KA. Histone Monoubiquitination in Chromatin Remodelling: Focus on the Histone H2B Interactome and Cancer. Cancers (Basel) 2020;12:E3462. [PMID: 33233707 DOI: 10.3390/cancers12113462] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Wessman S, Fuentes BB, Törngren T, Kvist A, Kokaraki G, Menkens H, Hjerpe E, Hugo Y, Petta TB, Borg Å, Carlson JW. Precision Oncology of High-Grade Ovarian Cancer Defined through Targeted Sequencing. Cancers (Basel) 2021;13:5240. [PMID: 34680387 DOI: 10.3390/cancers13205240] [Reference Citation Analysis]
8 Georgantzoglou N, Green D, Lefferts JA, Giannikaki L, Chliara E, Stavrianaki A, Kerr DA, Linos K. A Rare Case of Low-Grade Dedifferentiated Liposarcoma Presenting as a Pharyngeal Polyp: Avoiding a Pitfall With Significant Repercussions. Int J Surg Pathol 2021;:10668969211062859. [PMID: 34894818 DOI: 10.1177/10668969211062859] [Reference Citation Analysis]
9 Russi M, Marson D, Fermeglia A, Aulic S, Fermeglia M, Laurini E, Pricl S. The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer. Pharmacol Ther 2021;:108009. [PMID: 34619284 DOI: 10.1016/j.pharmthera.2021.108009] [Reference Citation Analysis]
10 Fierheller CT, Alenezi WM, Tonin PN. The Genetic Analyses of French Canadians of Quebec Facilitate the Characterization of New Cancer Predisposing Genes Implicated in Hereditary Breast and/or Ovarian Cancer Syndrome Families. Cancers (Basel) 2021;13:3406. [PMID: 34298626 DOI: 10.3390/cancers13143406] [Reference Citation Analysis]
11 Wu J, Aini A, Ma B. Mutations in exon region of BRCA1-related RING domain 1 gene and risk of breast cancer. Mol Genet Genomic Med 2022;:e1847. [PMID: 35084806 DOI: 10.1002/mgg3.1847] [Reference Citation Analysis]
12 Bueno-Martínez E, Sanoguera-Miralles L, Valenzuela-Palomo A, Lorca V, Gómez-Sanz A, Carvalho S, Allen J, Infante M, Pérez-Segura P, Lázaro C, Easton DF, Devilee P, Vreeswijk MPG, de la Hoya M, Velasco EA. RAD51D Aberrant Splicing in Breast Cancer: Identification of Splicing Regulatory Elements and Minigene-Based Evaluation of 53 DNA Variants. Cancers (Basel) 2021;13:2845. [PMID: 34200360 DOI: 10.3390/cancers13112845] [Reference Citation Analysis]
13 Stempa K, Wokołorczyk D, Kluźniak W, Rogoża-Janiszewska E, Malińska K, Rudnicka H, Huzarski T, Gronwald J, Gliniewicz K, Dębniak T, Jakubowska A, Lener M, Tomiczek-Szwiec J, Domagała P, Suszynska M, Kozlowski P, Kluz T, Naczk M, Lubiński J, Narod SA, Akbari MR, Cybulski C, On Behalf Of The Polish Hereditary Prostate Cancer Consortium. Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer? Cancers (Basel) 2021;13:5464. [PMID: 34771627 DOI: 10.3390/cancers13215464] [Reference Citation Analysis]